Y. Ferandin

发表

Large Diversity and Original Structures of Acyl-Homoserine Lactones in Strain MOLA 401, a Marine Rhodobacteraceae Bacterium

P. Lebaron, Raphaël Lami, D. Stien, 2017, Front. Microbiol..

Synthesis of novel 5-substituted indirubins as protein kinases inhibitors.

Olivier Lozach, Laurent Meijer, Thierry Besson, 2006, Bioorganic & medicinal chemistry.

Soluble 3',6-substituted indirubins with enhanced selectivity toward glycogen synthase kinase -3 alter circadian period.

C. Johnson, L. Meijer, A. Skaltsounis, 2008, Journal of medicinal chemistry.

Photoreactivity of indirubin derivatives

L. Meijer, P. Magiatis, L. Skaltsounis, 2008, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

Diversity of the intracellular mechanisms underlying the anti-tumor properties of indirubins

L. Meijer, Y. Ferandin, K. Bettayeb, 2007 .

Pyrazolo[1,5-a]-1,3,5-triazine as a purine bioisostere: access to potent cyclin-dependent kinase inhibitor (R)-roscovitine analogue.

Philippe Bernard, Florence Popowycz, Laurent Meijer, 2009, Journal of medicinal chemistry.

Synthesis and evaluation of new potent inhibitors of CK1 and CDK5, two kinases involved in Alzheimer’s disease

L. Meijer, O. Lozach, H. Galons, 2013, Medicinal Chemistry Research.

N-&-N, a new class of cell death-inducing kinase inhibitors derived from the purine roscovitine

L. Meijer, J. Endicott, G. Fournet, 2008, Molecular Cancer Therapeutics.

Synthesis and kinase inhibitory activity of novel substituted indigoids.

L. Meijer, C. Guguen-Guillouzo, O. Lozach, 2009, Bioorganic & medicinal chemistry.

Practical Synthesis of Roscovitine and CR8

L. Meijer, H. Galons, Y. Ferandin, 2009 .

Purification of CK1 by affinity chromatography on immobilised axin.

L. Meijer, Y. Ferandin, J. Reinhardt, 2007, Protein expression and purification.

Meriolins (3-(pyrimidin-4-yl)-7-azaindoles): synthesis, kinase inhibitory activity, cellular effects, and structure of a CDK2/cyclin A/meriolin complex.

L. Meijer, J. Endicott, O. Lozach, 2008, Journal of medicinal chemistry.

9-cyano-1-azapaullone (cazpaullone), a glycogen synthase kinase-3 (GSK-3) inhibitor activating pancreatic beta cell protection and replication.

L. Meijer, C. Kunick, O. Lozach, 2008, Journal of medicinal chemistry.

Anticancer Alkaloid Lamellarins Inhibit Protein Kinases

Poonsakdi Ploypradith, Olivier Lozach, Laurent Meijer, 2008, Marine drugs.

Modular asymmetric synthesis of aigialomycin D, a kinase-inhibitory scaffold.

L. Meijer, S. Barluenga, N. Winssinger, 2006, Angewandte Chemie.

Meriolins, a new class of cell death inducing kinase inhibitors with enhanced selectivity for cyclin-dependent kinases.

L. Meijer, J. Endicott, M. Kubbutat, 2007, Cancer research.

Design, synthesis, and testing of an 6-O-linked series of benzimidazole based inhibitors of CDK5/p25.

Laurent Meijer, Jeffry D Madura, L. Meijer, 2011, Bioorganic & medicinal chemistry.

CDK10/cyclin M is a protein kinase that controls ETS2 degradation and is deficient in STAR syndrome

L. Meijer, M. Flajolet, P. Colas, 2013, Proceedings of the National Academy of Sciences.

Roscovitine-derived, dual-specificity inhibitors of cyclin-dependent kinases and casein kinases 1.

P. Greengard, L. Meijer, M. Flajolet, 2008, Journal of medicinal chemistry.

7-Bromoindirubin-3′-oxime induces caspase-independent cell death

L. Meijer, F. Totzke, M. Knockaert, 2006, Oncogene.

Crystal Structure of Pyridoxal Kinase in Complex with Roscovitine and Derivatives*

L. Meijer, N. Gray, Ming-hui Li, 2005, Journal of Biological Chemistry.

First BRET-based screening assay performed in budding yeast leads to the discovery of CDK5/p25 interaction inhibitors.

V. Tan, P. Colas, O. Lozach, 2011, Biotechnology journal.

CR8, a potent and selective, roscovitine-derived inhibitor of cyclin-dependent kinases

L Meijer, L. Meijer, J. Endicott, 2008, Oncogene.

Novel Inverse Binding Mode of Indirubin Derivatives Yields Improved Selectivity for DYRK Kinases

Daniel Cappel, Vassilios Myrianthopoulos, Emmanuel Mikros, 2012, ACS medicinal chemistry letters.

Development of 5-benzylpaullones and paullone-9-carboxylic acid alkyl esters as selective inhibitors of mitochondrial malate dehydrogenase (mMDH).

L. Meijer, C. Kunick, M. Knockaert, 2010, European journal of medicinal chemistry.

Potent inhibitors of CDK5 derived from roscovitine: synthesis, biological evaluation and molecular modelling.

L. Meijer, N. Gresh, O. Lozach, 2013, Bioorganic & medicinal chemistry letters.

Synthesis and biological activities of aminopyrimidyl-indoles structurally related to meridianins.

L. Meijer, M. Prudhomme, E. Débiton, 2009, Bioorganic & medicinal chemistry.

Quorum Sensing and Quorum Quenching in the Mediterranean Seagrass Posidonia oceanica Microbiota

A. Escargueil, L. Intertaglia, Raphaël Lami, 2017, Front. Mar. Sci..

Genome Sequence of Maribius sp. Strain MOLA 401, a Marine Roseobacter with a Quorum-Sensing Cell-Dependent Physiology

L. Intertaglia, P. Lebaron, Raphaël Lami, 2014, Genome Announcements.

Synthesis and evaluation of new potent inhibitors of CK1 and CDK5, two kinases involved in Alzheimer’s disease

L. Meijer, O. Lozach, H. Galons, 2013, Medicinal Chemistry Research.

Synthesis, protein kinase inhibitory potencies, and in vitro antiproliferative activities of meridianin derivatives.

L. Meijer, O. Lozach, E. Débiton, 2011, Journal of medicinal chemistry.

An integrated computational approach to the phenomenon of potent and selective inhibition of aurora kinases B and C by a series of 7-substituted indirubins.

L. Meijer, A. Skaltsounis, E. Mikros, 2007, Journal of medicinal chemistry.

Roscovitine-derived, dual-specificity inhibitors of cyclin-dependent kinases and casein kinases 1.

P. Greengard, L. Meijer, M. Flajolet, 2008, Journal of medicinal chemistry.